Becoming the Managing Partner at 5AM Venture Management has been just the latest of great achievements by Dr. Scott M. Rocklage.
His educations started at University of California, Berkeley with a B.S. in Chemistry and moved on to Massachusetts institute of technology to earn his Ph.D in Chemistry where he conducted research in Nobel Prize winner Richard R. Schrock’s laboratory. Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift
Dr. Scott M. Rocklage then moved on to gain the approval of several drugs from the Food and Drug Administration and was the inventor or co-inventor of over 30 patents, and and has over 100 peer reviewed articles.
Dr. Scott M. Rocklage had not only great academic achievements, but also went on to attaing great achievements in the field of pharmaceutical business. His ventures in business start at Cubist Pharmaceuticals Inc.
where Dr. Rocklage was Director and moved to other leadership roles including his present role as the Chief Executive Officer at EPIRUS Bio-pharmaceuticals right before he joins the 5AM team in 2003 as a Venture Partner and has been Managing Partner since 2004.
Dr. Scott M. Rocklage was not only President and Chief Executive Officer at Amersham Health, Co-President at Ilypsa, Inc. and a multitude of other businesses to prove his worth in his field.
Dr. Rocklage has proved that he is effective at more positions than CEO or President. He currently serves as Chairman of the Board of Cidara Theraputics, Inc, Rennovia, Inc, and was on the board for Semprus BioSciences Corp. His academic achievements and business success has proven his worth in the field of pharmaceuticals.